• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Schering-Plough

Schering-Plough

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. UPDATE: Celebrities or not, inauguration price tag of $200 million could top record (even adjusted for inflation)

    UPDATE: Celebrities or not, inauguration price tag of $200 million could top record (even adjusted for inflation)

  2. Celebrities or not, inauguration price tag of $200 million could top record (even adjusted for inflation

    Celebrities or not, inauguration price tag of $200 million could top record (even adjusted for inflation

  3. Contrarian Buying at American Funds

    American's managers have been busy buying unloved large caps.

  4. This Pharma Firm Passes the Test

    Positive trial data for diabetes drug Januvia and strong first-quarter results keep Merck's stock undervalued and its wide moat intact.

  5. High-Priced Sale of Consumer Business Strengthens This Big Pharma Firm's Moat

    The sale to Bayer monetizes Merck's consumer unit at a strong valuation, and removes Merck from an area where it lacks scale.

  6. Homestead Value

    With a rock-solid belief in their strategy, the managers of Homestead Value confidently go about their business.

  7. Nanomagnetics Materials and Devices Market for Sensors, Separation, Imaging, Data Storage, Medical & Genetics and Other Application- Global Industry Perspective 2015 - 2021 - Research and Markets

    Nanomagnetics Materials and Devices Market for Sensors, Separation, Imaging, Data Storage, Medical & Genetics and Other Application- Global Industry Perspective 2015 - 2021 - Research and Markets

  8. Health-Care Investing Alive and Well

    Two veteran investors discuss the winners and losers of reform and where they're looking for future growth.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.